Radcliffe Capital Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Radcliffe Capital Management’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,000	Closed	-$7.18K	–	683
2023 Q1	$7.18K	Hold	150,000	–	–	﹤0.01%	581
2022 Q4	$1.54M	Hold	150,000	–	–	0.05%	545
2022 Q3	$1.51M	Hold	150,000	–	–	0.04%	767
2022 Q2	$1.5M	Hold	150,000	–	–	0.03%	797
2022 Q1	$1.5M	Hold	150,000	–	–	0.03%	779
2021 Q4	$1.49M	Buy	+150,000	New	+$75.3K	0.04%	681

Radcliffe Capital Management's IQMDW Position: Q2 2023 in Review

Radcliffe Capital Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 150,000 shares — an estimated $7.18K sold.

Radcliffe Capital Management first reported a position in IQMDW in Q4 2021 and held it in 6 quarters. The position peaked at $1.54M in Q4 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Radcliffe Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Radcliffe Capital Management sold 150,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $7.18K.
Radcliffe Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 6 quarters.
Radcliffe Capital Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $1.54M in Q4 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Radcliffe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.